Dr Elise Rowan
Trial Manager
- Email: elise.rowan@ncl.ac.uk
- Telephone: +44 (0) 191 222 5638
- Fax: +44 (0) 191 222 5762
- Address: Neurosurgical Trials Unit
3-4 Claremont Terrace
Newcastle University
Newcastle upon Tyne
NE2 4AE, UK
- Rowan EN, Gregson B, Mendelow AD. Difficulties with recruiting into neurosurgical clinical trials: Surgical Trial in IntraCerebral Haemorrhage II as an example.
British Journal of Neurosurgery 2011, 25(3), 435-436.
- Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, O'Brien JT, Kalaria RN. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors.
Brain 2011, 134(12), 3713-3724.
- Kenyon GM, Mendelow AD, Gregson BA, Rowan EN. Obtaining regulatory approval in multicentre randomised controlled trials: experiences in the STICH II trial.
British Journal of Neurosurgery 2011, 25(3), 352-356.
- Mendelow AD, Gregson BA, Mitchell PM, Murray GD, Rowan EN, Gholkar AR, STICH II Investigators. Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II) Protocol.
Trials 2011, 12(1), 124.
- Gregson BA, Rowan E, Mitchell P, Mendelow AD, STICH II Investigators. The Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II) - the First 300 Patients.
In: Stroke: International Stroke Conference. 2011, Los Angeles, California, USA: Lippincott Williams & Wilkins.
- Bhasin M, Rowan E, Edwards K, McKeith I. Cholinesterase inhibitors in dementia with Lewy bodies - A comparative analysis.
International Journal of Geriatric Psychiatry 2007, 22(9), 890-895.
- Rowan E, McKeith IG, Saxby BK, O'Brien JT, Burn D, Mosimann U, Newby J, Daniel S, Sanders J, Wesnes K. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Dementia and Geriatric Cognitive Disorders 2007, 23(3), 161-167.
- Rowan EN, Dickinson HO, Stephens S, Ballard C, Kalaria R, Kenny RA. Homocysteine and post-stroke cognitive decline.
Age and Ageing 2007. , 36(3), 339-343.
- Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(5), 585-589.
- Rowan E, Morris CM, Stephens S, Ballard C, Dickinson H, Rao H, Saxby BK, McLaren AT, Kalaria RN, Kenny RA. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age.
Stroke 2005, 36(9), 1864-1868.
- Rowan EN, Saxby BK, Askew KA, Thomas AJ, Manktelow TC, Wesner LA, McKeith IG. Improved attentional performance in DLB and PDD following donepezil treatment.
In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2004, Harrogate, UK: Sage Publications Ltd.
- Stephens S, Kenny RA, Rowan E, Allan L, Kalaria RN, Bradbury M, Ballard CG. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
International Journal of Geriatric Psychiatry 2004,19 11 1053-1057.
- Bradbury MP, Stephens S, Rowan E, Burton EJ, Kalaria R, Kenny RA, Ballard C. [abstract] White matter hyperintensities are associated with impairment of memory and attention in older stroke patients.
International Psychogeriatrics 2003, 15(s2), 299-299.
- Ballard C, Wesnes KA, O'Brien J, Stephens S, Burton E, Rowan E, Kalaria R, Kenny RA. Cognitive impairments in elderly stroke patients without dementia: Profile and MRI correlates.
In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
- Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease.
International Journal of Geriatric Psychiatry 2001, 16(5), 494-498.
